Graft-versus-host disease, Lancet, vol.373, issue.9674, pp.1550-61, 2009. ,
Hematopoietic stem cell transplantation, Stem Cells Cloning, vol.3, pp.105-122, 2010. ,
Alloantigen presentation and graft-versus-host disease: fuel for the fire, Blood, vol.127, issue.24, 2016. ,
DOI : 10.1182/blood-2016-02-697250
URL : http://www.bloodjournal.org/content/127/24/2963.full.pdf
Graft-versus-leukemia effects of transplantation and donor lymphocytes, Blood, vol.112, issue.12, pp.4371-83, 2008. ,
Reconstitution of the immune system after hematopoietic stem cell transplantation in humans, Semin Immunopathol, vol.30, issue.4, pp.425-462, 2008. ,
The best endpoint for acute GVHD treatment trials, Blood, issue.26, pp.5412-5419, 2010. ,
Advances in the treatment of acute graft-versus-host disease, J Cell Mol Med, vol.17, issue.8, pp.966-75, 2013. ,
Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, Expert Opin Investig Drugs, vol.25, issue.8, pp.957-72, 2016. ,
DOI : 10.1080/13543784.2016.1182498
URL : https://orbi.uliege.be/bitstream/2268/196156/4/368.pdf
Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation, Biol Blood Marrow Transplant, vol.14, issue.3, pp.335-378, 2008. ,
DOI : 10.1016/j.bbmt.2007.12.487
URL : https://doi.org/10.1016/j.bbmt.2007.12.487
Graft-versus-host disease prophylaxis in unrelated peripheral blood stem cell transplantation with post-transplantation cyclophosphamide, tacrolimus, and mycophenolate mofetil, Biol Blood Marrow Transplant, vol.22, issue.6, pp.1037-1079, 2016. ,
Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease, Biol Blood Marrow Transplant, vol.21, issue.4, pp.604-615, 2015. ,
Haploidentical hematopoietic transplantation: current status and future perspectives, Blood, vol.118, issue.23, pp.6006-6023, 2011. ,
DOI : 10.1182/blood-2011-07-338822
URL : http://www.bloodjournal.org/content/118/23/6006.full.pdf
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, issue.17, pp.17-17, 2010. ,
DOI : 10.1126/scitranslmed.3000116
URL : http://europepmc.org/articles/pmc2860737?pdf=render
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial, Biol Blood Marrow Transplant, vol.19, issue.11, pp.1638-1687, 2013. ,
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody, Am J Transplant, vol.12, issue.10, pp.2630-2670, 2012. ,
CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells, PLoS One, vol.28, issue.12, p.83139, 2013. ,
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28, MAbs, vol.6, issue.3, pp.697-707, 2014. ,
Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production, PLoS One, vol.12, issue.3, p.171822, 2017. ,
DOI : 10.1371/journal.pone.0171822
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171822&type=printable
FR104, an antagonist anti-CD28 monovalent Fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft, Am J Transplant, vol.15, issue.1, pp.88-100, 2015. ,
DOI : 10.1111/ajt.12964
URL : https://hal.archives-ouvertes.fr/inserm-02148443
Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection, J Am Soc Nephrol, vol.27, issue.12, pp.3577-88, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150329
Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis, J Immunol, vol.194, issue.4, pp.1454-66, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148517
Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis, Clin Exp Immunol, vol.183, issue.3, pp.405-423, 2016. ,
First-in-human study in healthy subjects with FR104, a pegylated monoclonal antibody fragment antagonist of CD28, J Immunol, vol.197, issue.12, pp.4593-602, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150993
Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase, Eur J Immunol, vol.42, issue.5, pp.1117-1145, 2012. ,
Selective CD28 antagonist blunts memory immune responses and promotes long-term control of skin inflammation in nonhuman primates, J Immunol, vol.196, issue.1, pp.274-83, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02150299
Using synthetic templates to design an unbiased multiplex PCR assay, Nat Commun, vol.4, p.2680, 2013. ,
A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model, BMC Med, vol.11, p.134, 2013. ,
CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk, Int Immunopharmacol, vol.15, issue.3, pp.638-683, 2013. ,
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am J Transplant, vol.11, issue.8, pp.1599-609, 2011. ,
Cytomegalovirus-infected cells resist T cell mediated killing in an HLArecognition independent manner, Front Microbiol, vol.7, p.844, 2016. ,
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin, Blood, vol.88, issue.8, pp.3230-3239, 1996. ,
Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-gammac-/-mouse model, Biol Blood Marrow Transplant, vol.18, issue.7, pp.1023-1058, 2012. ,
Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies, J Transl Med, vol.8, p.4, 2010. ,
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells, J Immunol, vol.152, issue.6, pp.2675-85, 1994. ,
The impact of memory T cells on rejection and the induction of tolerance, Transplantation, vol.82, issue.1, pp.1-9, 2006. ,
Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice, Am J Transplant, vol.2, issue.6, pp.501-510, 2002. ,
Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients, J Immunol, vol.169, issue.8, pp.4667-73, 2002. ,
Reversal of in vitro T cell clonal anergy by IL-2 stimulation, Int Immunol, vol.4, issue.6, pp.661-71, 1992. ,
Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapy, Cancer Immunol Immunother, vol.39, issue.3, pp.167-71, 1994. ,
Contribution of naive and memory T-cell populations to the human alloimmune response, Am J Transplant, vol.9, issue.9, pp.2057-66, 2009. ,
Virus-specific CD8+ ,
, T-cell memory determined by clonal burst size, Nature, vol.369, issue.6482, pp.652-656, 1994.
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J Exp Med, vol.192, issue.7, pp.1027-1061, 2000. ,
PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat Immunol, vol.2, issue.3, pp.261-269, 2001. ,
Strength of PD-1 signaling differentially affects T-cell effector functions, Proc Natl Acad Sci U S A, vol.110, issue.27, pp.2480-2489, 2013. ,
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors, Cancer Res, vol.73, issue.12, pp.3591-603, 2013. ,
Structure-function analysis of the CTLA-4 interaction with PP2A, BMC Immunol, vol.10, p.23, 2009. ,
Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt, J Biol Chem, vol.283, issue.4, pp.1882-92, 2008. ,
PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth, Mol Cell, vol.18, issue.1, pp.13-24, 2005. ,
Fungal infections in hematopoietic stem cell transplant recipients, Med Mycol, vol.46, issue.4, pp.293-302, 2008. ,
Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years, J Zhejiang Univ Sci B, vol.16, issue.9, pp.796-804, 2015. ,
Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture, PLoS One, vol.9, issue.11, p.111943, 2014. ,
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease, J Clin Invest, vol.109, issue.4, pp.549-57, 2002. ,
Graft-versus-host disease, Nat Rev Immunol, vol.7, issue.5, pp.340-52, 2007. ,
Mouse models of bone marrow transplantation, Biol Blood Marrow Transplant, vol.14, issue.1, pp.129-164, 2008. ,
Mouse models of graft-versus-host disease: advances and limitations, Dis Model Mech, vol.4, issue.3, pp.318-351, 2011. ,
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo, J Exp Med, vol.165, issue.2, pp.302-321, 1987. ,
CD28/B7 system of T cell costimulation, Annu Rev Immunol, vol.14, pp.233-58, 1996. ,
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics, J Exp Med, vol.185, issue.3, pp.393-403, 1997. ,
Transplantation of anergic histoincompatible bone marrow allografts, N Engl J Med, vol.340, issue.22, pp.1704-1718, 1999. ,
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies, Blood, vol.112, issue.6, pp.2232-2273, 2008. ,
Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation, Cell Transplant, vol.21, issue.9, pp.2047-61, 2012. ,
Graft-versus-leukemia reactions after bone marrow transplantation, Blood, vol.75, issue.3, pp.555-62, 1990. ,
Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, issue.7077, pp.682-689, 2006. ,
T cell exhaustion, Nat Immunol, vol.12, issue.6, pp.492-501, 2011. ,
The CD28 and CTLA-4 receptors associate with the serine/ threonine phosphatase PP2A, Immunity, vol.13, issue.3, pp.31-36, 2000. ,
Inhibition of CTLA-4 function by the regulatory subunit of serine/ threonine phosphatase 2A, J Immunol, vol.168, issue.10, pp.5070-5078, 2002. ,
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, Mol Cell Biol, vol.25, issue.21, pp.9543-53, 2005. ,
DOI : 10.1128/mcb.25.21.9543-9553.2005
URL : https://mcb.asm.org/content/25/21/9543.full.pdf
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning, Br J Haematol, vol.116, issue.2, pp.827-860, 2002. ,